Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives

por De Goycoechea, Diego, Stalder, Gregoire, Martins, Filipe, Duchosal, Michel A.
Publicado 2019

Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia

por Matsumoto, Saki, Biniecka, Paulina, Bellotti, Axel, Duchosal, Michel A., Nahimana, Aimable
Publicado 2023

Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability

por Pellegrin, Maxime, Bouzourène, Karima, Aubert, Jean-François, Nahimana, Aimable, Duchosal, Michel A., Mazzolai, Lucia
Publicado 2018

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies

por Breton, Caroline S, Nahimana, Aimable, Aubry, Dominique, Macoin, Julie, Moretti, Pierre, Bertschinger, Martin, Hou, Samuel, Duchosal, Michel A, Back, Jonathan
Publicado 2014

Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis

por Stalder, Grégoire, Que, Yok Ai, Calzavarini, Sara, Burnier, Laurent, Kosinski, Christophe, Ballabeni, Pierluigi, Roger, Thierry, Calandra, Thierry, Duchosal, Michel A., Liaudet, Lucas, Eggimann, Philippe, Angelillo-Scherrer, Anne
Publicado 2016

Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia

por ElMokh, Oussama, Matsumoto, Saki, Biniecka, Paulina, Bellotti, Axel, Schaeuble, Karin, Piacente, Francesco, Gallart-Ayala, Hector, Ivanisevic, Julijana, Stamenkovic, Ivan, Nencioni, Alessio, Nahimana, Aimable, Duchosal, Michel A.
Publicado 2022

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent

por Cloux, Anne-Julie, Aubry, Dominique, Heulot, Mathieu, Widmann, Christian, ElMokh, Oussama, Piacente, Francesco, Cea, Michele, Nencioni, Alessio, Bellotti, Axel, Bouzourène, Karima, Pellegrin, Maxime, Mazzolai, Lucia, Duchosal, Michel A., Nahimana, Aimable
Publicado 2019

Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery

por Ghanem, Moustafa S., Caffa, Irene, Del Rio, Alberto, Franco, Jorge, Parenti, Marco Daniele, Monacelli, Fiammetta, Cea, Michele, Khalifa, Amr, Nahimana, Aimable, Duchosal, Michel A., Ravera, Silvia, Bertola, Nadia, Bruzzone, Santina, Nencioni, Alessio, Piacente, Francesco
Publicado 2022

Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones

por Rovó, Alicia, Gavillet, Mathilde, Drexler, Beatrice, Keller, Peter, Schneider, Jenny Sarah, Colucci, Giuseppe, Beauverd, Yan, van Dorland, Hendrika Anette, Pollak, Matthias, Schmidt, Adrian, De Gottardi, Andrea, Bissig, Marina, Lehmann, Thomas, Duchosal, Michel A., Zeerleder, Sacha
Publicado 2023

Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies

por Biniecka, Paulina, Matsumoto, Saki, Belotti, Axel, Joussot, Jessie, Bai, Jian Fei, Majjigapu, Somi Reddy, Thoueille, Paul, Spaggiari, Dany, Desfontaine, Vincent, Piacente, Francesco, Bruzzone, Santina, Cea, Michele, Decosterd, Laurent A., Vogel, Pierre, Nencioni, Alessio, Duchosal, Michel A., Nahimana, Aimable
Publicado 2023

Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients

por Obeid, Michel, Suffiotti, Madeleine, Pellaton, Celine, Bouchaab, Hasna, Cairoli, Anne, Salvadé, Vanja, Stevenel, Caroline, Hottinger, Rosemary, Pythoud, Catherine, Coutechier, Lucie, Molinari, Laura, Trono, Didier, Ribi, Camillo, Gottardo, Raphael, Fenwick, Craig, Pascual, Manuel, Duchosal, Michel A., Peters, Solange, Pantaleo, Giuseppe
Publicado 2022